Fox Chase Cancer Center Regulatory Contact — Philadelphia, Pennsylvania

Fox Chase Cancer Center Regulatory Contact is a clinical research site located in Philadelphia, Pennsylvania, United States 19111-2497.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Fox Chase Cancer Center Regulatory Contact has participated in 1 clinical trials.

Therapeutic areas: Lymphoma, Mantle- Cell.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Fox Chase Cancer Center Regulatory Contact?

Fox Chase Cancer Center Regulatory Contact has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Fox Chase Cancer Center Regulatory Contact conducted?

Fox Chase Cancer Center Regulatory Contact has 1 clinical trials on record. Their work covers Lymphoma, Mantle- Cell.

Is Fox Chase Cancer Center Regulatory Contact accredited by Crixeo Health?

Fox Chase Cancer Center Regulatory Contact has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Fox Chase Cancer Center Regulatory Contact?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.